JP2006506979A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506979A5
JP2006506979A5 JP2004536574A JP2004536574A JP2006506979A5 JP 2006506979 A5 JP2006506979 A5 JP 2006506979A5 JP 2004536574 A JP2004536574 A JP 2004536574A JP 2004536574 A JP2004536574 A JP 2004536574A JP 2006506979 A5 JP2006506979 A5 JP 2006506979A5
Authority
JP
Japan
Prior art keywords
biomarkers
sample
symptoms
osteoarthritis
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004536574A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506979A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/029136 external-priority patent/WO2004024892A2/en
Publication of JP2006506979A publication Critical patent/JP2006506979A/ja
Publication of JP2006506979A5 publication Critical patent/JP2006506979A5/ja
Pending legal-status Critical Current

Links

JP2004536574A 2002-09-12 2003-09-12 変形性関節症のための治療標的の診断および同定に特に有用な配列の同定 Pending JP2006506979A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41018002P 2002-09-12 2002-09-12
PCT/US2003/029136 WO2004024892A2 (en) 2002-09-12 2003-09-12 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis

Publications (2)

Publication Number Publication Date
JP2006506979A JP2006506979A (ja) 2006-03-02
JP2006506979A5 true JP2006506979A5 (enExample) 2006-11-02

Family

ID=31994085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004536574A Pending JP2006506979A (ja) 2002-09-12 2003-09-12 変形性関節症のための治療標的の診断および同定に特に有用な配列の同定

Country Status (6)

Country Link
US (2) US7452667B2 (enExample)
EP (1) EP1581652A4 (enExample)
JP (1) JP2006506979A (enExample)
AU (1) AU2003272465A1 (enExample)
CA (1) CA2495252A1 (enExample)
WO (1) WO2004024892A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128270B1 (en) 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US7662573B2 (en) 2004-08-18 2010-02-16 The United States Of America As Represented By The Department Of Health And Human Services Methods for evaluating osteoarthritis risk
CN103497993A (zh) * 2005-02-07 2014-01-08 基因信息公司 轻度骨关节炎生物标志物及其用途
US8224579B2 (en) * 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
BRPI0711011A2 (pt) * 2006-05-18 2011-08-23 Molecular Profiling Inst Inc método para a determinação da intervenção médica para um estado de doença, método para a identificação de uma terapia de droga com capacidade de interação com um alvo molecular e sistema para a determinação da intervenção médica individualizada para um estado de doença
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
JP2011117813A (ja) * 2009-12-02 2011-06-16 Hokuriku Univ 変形性関節症のマーカーおよびそれを用いた診断
EP2542701A4 (en) * 2010-03-05 2013-08-21 Univ Missouri BIOMARKER FOR OSTEOARTHRITIS
EP2837373B1 (en) 2010-06-04 2017-04-05 Kao Corporation Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
US20150049177A1 (en) * 2012-02-06 2015-02-19 Biooptico Ab Camera Arrangement and Image Processing Method for Quantifying Tissue Structure and Degeneration
US9034606B2 (en) * 2012-08-23 2015-05-19 New England Biolabs, Inc. Detection of an amplification reaction product using pH-sensitive dyes
CA2944994C (en) 2014-04-24 2021-01-19 Diassess Inc. Colorimetric detection of nucleic acid amplification
WO2017160836A1 (en) 2016-03-14 2017-09-21 Diassess Inc. Systems and methods for performing biological assays
EP3429543B1 (en) 2016-03-14 2024-11-20 Pfizer Inc. Selectively vented biological assay devices and associated methods
PT3430378T (pt) 2016-03-14 2022-09-15 Lucira Health Inc Dispositivos e métodos para modificar propriedades ópticas
CA3214851A1 (en) 2016-03-14 2017-09-21 Lucira Health, Inc. Devices and methods for biological assay sample preparation and delivery
US11080848B2 (en) 2017-04-06 2021-08-03 Lucira Health, Inc. Image-based disease diagnostics using a mobile device
US10549275B2 (en) 2017-09-14 2020-02-04 Lucira Health, Inc. Multiplexed biological assay device with electronic readout
WO2019055135A1 (en) 2017-09-14 2019-03-21 Diassess Inc. MULTIPLEXED BIOLOGICAL ASSAY DEVICE WITH ELECTRONIC READING
USD910200S1 (en) 2018-12-21 2021-02-09 Lucira Health, Inc. Test tube
USD953561S1 (en) 2020-05-05 2022-05-31 Lucira Health, Inc. Diagnostic device with LED display
USD962470S1 (en) 2020-06-03 2022-08-30 Lucira Health, Inc. Assay device with LCD display
KR102466691B1 (ko) * 2020-06-16 2022-11-14 한양대학교 에리카산학협력단 Tsg6 억제제를 포함하는 전이성 고형암 치료용 조성물
CN113249464B (zh) * 2021-04-13 2022-09-27 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 环状rna作为骨关节炎标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP0705842A2 (en) * 1994-10-06 1996-04-10 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with 1L-1beta
US20020119452A1 (en) * 2000-01-18 2002-08-29 Phippard Deborah J. Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
EP1404868A2 (en) * 2001-02-28 2004-04-07 Chondrogene Inc. Compositions and methods relating to osteoarthritis

Similar Documents

Publication Publication Date Title
JP2006506979A5 (enExample)
CN113227468A (zh) 感染性疾病的检测和预测
US12110556B2 (en) Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS)
WO2011008349A2 (en) Methods of identifying infectious disease and assays for identifying infectious disease
US20210254179A1 (en) Set of genes for molecular classifying of medulloblastoma and use thereof
JP2020524987A (ja) 妊娠高血圧腎症に特異的な循環rnaシグネチャー
AU2020343336A1 (en) Systems, methods, and compositions for the rapid early-detection of host RNA biomarkers of infection and early identification of COVID-19 coronavirus infection in humans
CN110283903A (zh) 用于诊断胰腺炎的肠道微生物菌群
CN111411150B (zh) 诊断肌少症的肠道菌群及其应用
CN107586862A (zh) 肠道菌群在儿童反复呼吸道感染诊断中的应用
CN103290135A (zh) 一种自闭症基因的筛查方法
IL285031A (en) Diagnosis of inflammatory bowel diseases
WO2015079060A2 (en) Mirnas as advanced diagnostic tool in patients with cardiovascular disease, in particular acute myocardial infarction (ami)
JP2019524115A (ja) 気分障害検査用バイオマーカーとしてのrna編集
JP2008547006A5 (enExample)
WO2005056839A3 (de) Primer und sonden zum nachweis genitaler hpv-genotypen
CN105838720B (zh) Ptprq基因突变体及其应用
WO2007056332A3 (en) Molecular diagnosis of autoimmune diseases
US20210087634A1 (en) Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
CN109468373A (zh) 一种与帕金森发生发展相关的生物标志物
CN115772558A (zh) 一种用于肝衰竭疾病转归预后评价的试剂盒及应用及应用方法
DE60334408D1 (de) Nsäuren
CN112458162A (zh) 器官移植ddcfDNA检测试剂和方法
CN113444784B (zh) 重症先天性中性粒细胞减少症检测引物组合物及应用
CN104164427B (zh) 一种与吸烟成瘾相关的snp标志物及其应用